STROSutro BiopharmaSTRO info
$3.95info-1.50%24h
Global rank16153
Market cap$240.77M
Change 7d-
YTD Performance-7.06%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Sutro Biopharma (STRO) Stock Overview

    Sutro Biopharma, Inc. operates as a clinical-stage oncology company. It develops site-specific and novel-format antibody drug conjugates (ADC) that enables its proprietary integrated cell-free protein synthesis platform, XpressCF and XpressCF+. The company's product candidates include STRO-001, an ADC directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. Its pre-clinical product candidate STRO-003, a ADC directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1) for the treatment of solid tumors. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology; EMD Serono to develop ADCs for multiple cancer targets; and Astellas Pharma Inc. to develop ADC. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

    STRO Stock Information

    Symbol
    STRO
    Address
    111 Oyster Point BoulevardSouth San Francisco, CA 94080United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.sutrobio.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    650 881 6500

    Sutro Biopharma (STRO) Price Chart

    -
    Value:-

    Sutro Biopharma Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $3.95
    N/A
    Market Cap
    $240.77M
    N/A
    Shares Outstanding
    60.95M
    N/A
    Employees
    298.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org